Congestive Heart Failure (CHF) Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for Congestive Heart Failure trials.

Effective solutions for advancing Congestive Heart Failure research

At Signant Health, we understand the complexities inherent in congestive heart failure (CHF) trials. From patient-focused technology solutions to our in-house roster of clinical science experts, you can be sure your trials generate review-ready data while minimizing burdens of participation.  

Despite advances in the management of congestive heart failure (CHF), morbidity and mortality remain high, emphasizing the need for continued research to develop new and improved treatments. At Signant, our global cardiovascular clinical development expertise, scientific leadership, and patient-centered solutions within Signant SmartSignals suite help sponsors and CROs capture reliable endpoint data while optimizing the participation experience.

wired-gradient-1249-heart-beat-hover-heart-beat

Why Signant Health

  • Capture High-Quality PRO Data
  • Make Study Participation More Convenient
  • Maximize Study IP Efficiency
  • Support Endpoints & Monitoring with Objective Physical Activity Data
  • Capture High-Quality PRO Data

    Capture High-Quality PRO Data

    Signant's eCOA solution provides clinicians and patients with tools to improve the assessment experience: Electronic administration of PROs such as CaReQoL, KCCQ, and MLHQ makes it easier to complete them at home or site, and produces more reliable data. Video-assisted patient engagement features within a single patient app also help keep participants on track and adherent.
     
     

  • Make Study Participation More Convenient

    Make Study Participation More Convenient 

     CHF patients suffer from shortness of breath, fatigue, and mobility challenges that make it difficult to travel to the clinic for study visits. Signant SmartSignals Telemedicine provides a comprehensive platform to make virtual visits easy for patients and sites alike: Patients can self-schedule assessments and request "walk-in" consultations, and sites can conduct more frequent safety and monitoring check-ins.  
     
     

  • Maximize Study IP Efficiency

    Maximize Study IP Efficiency 

    Take control of supply management for numerous medications and simplify randomization for multi-arm trial designs with Signant's global RTSM solution. Our agile design process will help you launch quickly and manage mid-study changes with ease. Plus, a dedicated team of biostatisticians and logistics experts experienced in CHF protocols will support your program no matter how or where you conduct trials. 
     
     

  • Support Endpoints & Monitoring with Objective Physical Activity Data

    Support Endpoints & Monitoring with Objective Physical Activity Data 

     Signant SmartSignals eCOA makes it easy to capture real-time, objective physical activity data with no additional burden on patients. Seamless integration between the wrist-worn ActiGraph device and our eCOA solution enable study teams to view objective measures of physical activity alongside COA data, providing a more comprehensive understanding about how CHF symptoms and treatments impact patients' quality of life.
     
     

Comprehensive Congestive Heart Failure experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our Congestive Heart Failure trial resources
SOLUTION BROCHURE

Congestive Heart Failure Trial Solutions Overview


GET INSIGHTS
VIDEO

Congestive Heart Failure Trial Solutions


WATCH [2 MIN]
Q&A Interview

Increasing the Usefulness of COAs in Heart Failure Research

 
READ INTERVIEW

Ready to learn more?

Discover how Signant can support your current or upcoming CHF trials.